Clinical Trial Update: Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Biomatrix and Gazelle in ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Biomatrix
• Gazelle

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: ST-elevation Myocardial Infarction | Phase 4 | Status: COMPLETED